Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Retatrutide is a triple receptor agonist , meaning it is designed to activate three distinct hormone receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
What Each Compound Does Retatrutide (LY3437943) is a triple agonist: GLP-1 (cuts appetite, slows the stomach), GIP (improves insulin signaling), and glucagon (raises energy use and fat burning)
4 This type of medication was approved by the FDA in 2005 and is generally an injectable delivered in the fatty tissue present just under the skin.4 GLP-1 agonists are prescribed by a doctor who may decide that they are appropriate for an individual based on their specific needs
These lifestyle pillars are essential for maintaining muscle and bone health, preventing significant weight regain and supporting long-term cardiovascular and metabolic health
Avoid sugar consumption: Limiting refined sugars intake helps protect collagen and elastin from damage, keeping the skin firmer and slowing premature aging
has already achieved significant results in diabetes treatment and weight management
